Hand, Foot, and Mouth Disease (HFMD)

01Pathophysiology

Hand, foot, and mouth disease (HFMD) is caused by non-polio enteroviruses, most commonly Coxsackievirus A16 and Enterovirus 71. These are single-stranded RNA viruses belonging to the Picornaviridae family. Understanding the route of infection explains the entire clinical picture.

The virus enters through the oropharyngeal and intestinal mucosa via fecal-oral transmission, respiratory droplets, or direct contact with vesicular fluid. After initial replication in the pharyngeal lymphoid tissue (Waldeyer's ring) and Peyer patches of the small intestine, the virus undergoes a primary viremia, seeding the reticuloendothelial system (lymph nodes, spleen, liver). A secondary viremia follows, which is responsible for dissemination to the skin and oral mucosa, producing the characteristic enanthem and exanthem.

The oral ulcers explain the chief complaint of odynophagia and refusal to eat. Toddlers who cannot verbalize pain will present with drooling and irritability. The vesicular lesions on the hands and feet correspond to viral tropism for the eccrine glands and surrounding epithelium in acral skin. The buttocks are commonly involved in diaper-aged children because of local moisture and skin occlusion, not because of fecal contamination of the rash itself.

A critically testable point is the difference between Coxsackievirus A16 and Enterovirus 71. While A16 causes the classic benign course, EV-71 is associated with severe neurologic complications including aseptic meningitis, brainstem encephalitis, acute flaccid paralysis (polio-like syndrome), and pulmonary edema. When a vignette describes HFMD with neurologic deterioration, think EV-71.

Coxsackievirus A6 has emerged as a cause of atypical HFMD, producing more widespread vesiculobullous lesions that can involve the trunk and extremities broadly, sometimes mimicking eczema herpeticum. This atypical distribution is a known exam distractor.

02Classification and Clinical Manifestation

Onychomadesis (painless shedding of fingernails or toenails 4-8 weeks after infection) is a late finding increasingly recognized after Coxsackievirus A6 infection. Exam vignettes may present a child with a history of a febrile vesicular illness weeks prior and now has "nails falling off." This is benign and self-resolving; nails regrow normally.

03Diagnostic Workup

In routine clinical practice and on exams, HFMD is a clinical diagnosis. The combination of fever, oral vesicles/ulcers, and vesicular exanthem on the palms and soles in a young child is essentially pathognomonic. No laboratory confirmation is needed for typical cases.

RT-PCR becomes important in two scenarios. First, during outbreaks in daycare or institutional settings where public health surveillance requires serotype identification. Second, when the presentation is atypical or severe, particularly if neurologic symptoms are present, because identifying EV-71 has prognostic and public health implications.

If a vignette presents a child with HFMD who then develops lethargy, myoclonus, ataxia, or autonomic instability, the next best step is a lumbar puncture to evaluate for aseptic meningitis or encephalitis, along with RT-PCR of the CSF for enterovirus. The CSF will show the classic viral pattern: lymphocytic pleocytosis with normal glucose.

Stool viral culture remains positive for weeks after clinical resolution, so a positive stool culture alone does not confirm active disease; it must be interpreted in clinical context.

04Management and Treatment

There is no antiviral therapy or vaccine for HFMD in most countries. Management is entirely supportive. The most testable management concept is recognizing and treating dehydration caused by painful oral ulcers that lead to refusal to drink.

For pain management in the acute phase, acetaminophen at 10-15 mg/kg per dose every 4-6 hours (maximum 75 mg/kg/day) or ibuprofen at 5-10 mg/kg per dose every 6-8 hours (maximum 40 mg/kg/day) are both appropriate. Ibuprofen should not be used in infants younger than 6 months.

Aspirin is contraindicated in children with viral illness due to the risk of Reye syndrome. This is a classic exam trap if the vignette presents a febrile child with HFMD and asks about appropriate antipyretic choices.

Topical oral analgesics can provide temporary relief. In children old enough to swish and spit, mixtures containing diphenhydramine elixir and aluminum/magnesium hydroxide antacid are commonly used. Viscous lidocaine should be avoided in young children and infants because of the risk of seizures and cardiac toxicity from inadvertent swallowing.

Children should be kept out of daycare or school until they are afebrile and oral lesions have resolved, though it is important to counsel parents that fecal shedding persists for several weeks, making hand hygiene the cornerstone of prevention.

For severe EV-71 disease with neurologic involvement, treatment is supportive and requires ICU-level care. There is no established antiviral regimen. Intravenous immunoglobulin (IVIG) has been used anecdotally in EV-71 brainstem encephalitis, but robust evidence supporting routine use is lacking.

05Differential Diagnosis and Distractors

The single most important differential on the exam is herpangina versus HFMD. Both are caused by Coxsackieviruses. The discriminating feature is anatomical distribution: herpangina produces posterior oral lesions only, while HFMD produces anterior oral lesions plus the characteristic acral vesicles on the hands and feet.

06Traps and High-Yield Pearls

The most common way students lose points on HFMD questions is by confusing it with herpangina. Both diseases are caused by enteroviruses and share overlapping demographics and seasons. The vignette will deliberately describe oral vesicles, and students must pay close attention to two things: the anatomical location of the oral lesions (anterior versus posterior) and whether there is an accompanying rash on the extremities. If the vignette mentions vesicles on the palms, soles, or both, HFMD is the answer. If only the posterior pharynx is involved with no skin findings, herpangina is correct.

A second common trap is the question that describes HFMD with neurologic symptoms (altered consciousness, tremor, ataxia) to see whether you recognize the association with Enterovirus 71 and know to proceed with lumbar puncture and RT-PCR rather than simply providing reassurance and supportive care.

Third, watch for vignettes asking about management where aspirin appears as an answer choice in a febrile child. This tests your knowledge of Reye syndrome risk in pediatric viral illness. Always choose acetaminophen or ibuprofen instead.

Finally, a delayed presentation question may show a child who had a febrile vesicular illness weeks ago and now presents with nail shedding (onychomadesis). This is benign and self-limited. The correct answer is reassurance, not a workup for dermatologic or systemic disease. The core competency being tested across all these scenarios is pattern recognition of a classic pediatric viral exanthem and knowing when the routine self-limited course shifts to a presentation requiring further investigation.